Literature DB >> 12574090

Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats.

Oscar H Cingolani1, Xiao-Ping Yang, Maria A Cavasin, Oscar A Carretero.   

Abstract

Hypertensive heart disease is characterized by early development of hypertrophy and fibrosis that leads to heart failure (HF). HF develops in spontaneously hypertensive rats (SHR) after 18 months; however, it is not clear whether hypertrophy leads to altered cardiac performance at an earlier age in these rats. We studied cardiac performance in 10- to 11-month-old SHR and age-matched Wistar-Kyoto rats (WKY), using presssure-volume (PV) conductance catheter system to evaluate systolic and diastolic function in vivo at different preloads, including preload recruitable stroke work (PRSW), +dP/dt, and its relation to end-diastolic volume (+dP/dt-EDV) and preload-adjusted maximal power (PWR(max)-EDV(2)) as well as the time constant of left ventricular pressure decay, tau (tau), as an index of relaxation. The slope of the end-diastolic pressure-volume relation (EDPVR) and the ex vivo PV relation, both indexes of stiffness, were also calculated for each heart, and the Doppler E/A ratio was determined. In addition, plasma samples were obtained to assess B-type natriuretic peptide levels (BNP). We found that PRSW was higher in SHR than in WKY (174.5+/-15.6 versus 92.6+/-18.9 mm Hg; P<0.01). +dP/dt and +dP/dt-EDV were also enhanced in SHR versus WKY (9125+/-662 versus 6633+/-392 mm Hg/sec, P<0.01, and 28.14+/-4.35 versus 12.7+/-2.8 mm Hg/s per micro L, P<0.02). In addition, PWR-EDV(2) was elevated in SHR (7.3+/-1.5 versus 3.1+/-0.6 mW/ micro L(2)). Tau was prolonged in SHR (14.5+/-1 ms versus 10.8+/-0.8 for WKY, P<0.02) and EDPVR was significantly greater in SHR than in WKY (0.01+/-0.005 versus 0.004+/-0.001, P<0.05). The ex vivo pressure-volume relation was also steeper for SHR and the E/A ratio was 2.53+/-0.15 for SHR versus 1.67+/-0.08 for WKY (P<0.02). BNP was 45+/-2.5 pg/mL for SHR and 33.3+/-1.8 pg/mL for WKY (P<0.02). Taken together, these data suggest that at 10 to 11 months of age, before HF develops, SHR have increased systolic performance accompanied by delayed relaxation and increased diastolic stiffness.

Entities:  

Mesh:

Year:  2003        PMID: 12574090     DOI: 10.1161/01.hyp.0000052832.96564.0b

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

1.  Dose-dependent toxic effects of high-dose estrogen on renal and cardiac injury in surgically postmenopausal mice.

Authors:  Xiaomei Meng; Xiangguo Dai; Tang-Dong Liao; Martin D'Ambrosio; Fangfei Wang; James J Yang; Xiao-Ping Yang
Journal:  Life Sci       Date:  2010-11-11       Impact factor: 5.037

2.  In vivo assessment of myocardial stiffness with acoustic radiation force impulse imaging.

Authors:  Stephen J Hsu; Richard R Bouchard; Douglas M Dumont; Patrick D Wolf; Gregg E Trahey
Journal:  Ultrasound Med Biol       Date:  2007-08-15       Impact factor: 2.998

3.  When early life growth restriction in rats is followed by attenuated postnatal growth: effects on cardiac function in adulthood.

Authors:  Vladislava Zohdi; James T Pearson; Michelle M Kett; Paul Lombardo; Michal Schneider; M Jane Black
Journal:  Eur J Nutr       Date:  2014-08-13       Impact factor: 5.614

4.  CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages.

Authors:  Lei Yang; Li Ni; Quanlu Duan; Xingxu Wang; Chen Chen; Song Chen; Sandip Chaugai; D C Zeldin; Jia Rong Tang; Dao Wen Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-02-14       Impact factor: 3.072

5.  Exercise training improves systolic function in hypertensive myocardium.

Authors:  Joseph R Libonati; Abdelkarim Sabri; Canhua Xiao; Scott M Macdonnell; Brian F Renna
Journal:  J Appl Physiol (1985)       Date:  2011-09-15

6.  Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.

Authors:  Ying Sun; Oscar A Carretero; Jiang Xu; Nour-Eddine Rhaleb; Fangfei Wang; Chunxia Lin; James J Yang; Patrick J Pagano; Xiao-Ping Yang
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

7.  Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling.

Authors:  Jiali Nie; Quanlu Duan; Mengying He; Xianqing Li; Bei Wang; Chi Zhou; Lujin Wu; Zheng Wen; Chen Chen; Dao Wu Wang; Katherina M Alsina; Xander H T Wehrens; Dao Wen Wang; Li Ni
Journal:  J Cell Physiol       Date:  2018-11-29       Impact factor: 6.384

8.  Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.

Authors:  Sándor Bátkai; Pál Pacher; Douglas Osei-Hyiaman; Svetlana Radaeva; Jie Liu; Judith Harvey-White; László Offertáler; Ken Mackie; M Audrey Rudd; Richard D Bukoski; George Kunos
Journal:  Circulation       Date:  2004-09-27       Impact factor: 29.690

9.  Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease.

Authors:  Jan Monti; Judith Fischer; Svetlana Paskas; Matthias Heinig; Herbert Schulz; Claudia Gösele; Arnd Heuser; Robert Fischer; Cosima Schmidt; Alexander Schirdewan; Volkmar Gross; Oliver Hummel; Henrike Maatz; Giannino Patone; Kathrin Saar; Martin Vingron; Steven M Weldon; Klaus Lindpaintner; Bruce D Hammock; Klaus Rohde; Rainer Dietz; Stuart A Cook; Wolf-Hagen Schunck; Friedrich C Luft; Norbert Hubner
Journal:  Nat Genet       Date:  2008-05       Impact factor: 38.330

10.  The role of the Frank-Starling law in the transduction of cellular work to whole organ pump function: a computational modeling analysis.

Authors:  Steven A Niederer; Nicolas P Smith
Journal:  PLoS Comput Biol       Date:  2009-04-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.